The potential of antagonism with BBG for the treatment of ALS was proposed, but it was claimed that the treatment was gender-dependent, although this varied in different studies using the SOD1-G93A mouse model of ALS: more effective in males [109], more effective in females [110] and no difference between the sexes [111]. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.